CD226 and hepatocellular carcinoma: In agreement with previous findings in the NKp30/B7-H6 axis from our laboratory [24], we found that DNAM-1 downregulation depended in the engagement of DNAM-1 by CD155, there also being an association with CD155 expression in HCC cells.